Tapewire

Nasdaq · USD

TARS

Tarsus Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
1836
SEC CIK
0001819790
Parsed reports
328

Last 12 months

Inside the activity.

0 purchase rows · 59 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202509
Jan 202604
Feb 202600
Mar 2026026
Apr 202600
May 202600
Jun 202606
Jul 202600
Aug 202600
Sep 2026014
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 22, 2023 Filed Jun 26, 2023 21:56 UTC GrantRestricted Stock Units · Derivative 3,350 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000058 · wk-form4_1687816565.xml · derivative · entry 2

Goldberg Andrew D. · CIK 0001827722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,350

Underlying: Common Stock · 3,350 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 21:56 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $17.99 $0.00
Disclosure

SEC source: 0001819790-23-000058 · wk-form4_1687816565.xml · derivative · entry 1

Goldberg Andrew D. · CIK 0001827722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 21:49 UTC GrantRestricted Stock Units · Derivative 3,350 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000056 · wk-form4_1687816146.xml · derivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,350

Underlying: Common Stock · 3,350 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 21:49 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $17.99 $0.00
Disclosure

SEC source: 0001819790-23-000056 · wk-form4_1687816146.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 21:47 UTC GrantRestricted Stock Units · Derivative 3,350 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000054 · wk-form4_1687816019.xml · derivative · entry 2

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,350

Underlying: Common Stock · 3,350 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 21:47 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $17.99 $0.00
Disclosure

SEC source: 0001819790-23-000054 · wk-form4_1687816019.xml · derivative · entry 1

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 21:45 UTC GrantRestricted Stock Units · Derivative 3,350 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000052 · wk-form4_1687815920.xml · derivative · entry 2

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,350

Underlying: Common Stock · 3,350 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 21:45 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $17.99 $0.00
Disclosure

SEC source: 0001819790-23-000052 · wk-form4_1687815920.xml · derivative · entry 1

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 21:42 UTC GrantRestricted Stock Units · Derivative 3,350 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000050 · wk-form4_1687815744.xml · derivative · entry 2

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,350

Underlying: Common Stock · 3,350 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 21:42 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $17.99 $0.00
Disclosure

SEC source: 0001819790-23-000050 · wk-form4_1687815744.xml · derivative · entry 1

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 21, 2023 Filed Jun 23, 2023 20:29 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 8,000 $18.63 $149,040.00
Disclosure

SEC source: 0001819790-23-000048 · wk-form4_1687552162.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 1,023,006

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $18.35 to $18.84. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:27 UTC Exercise / conversionRestricted Stock Units · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000046 · wk-form4_1687386442.xml · derivative · entry 2

Crane Rosemary A · CIK 0001443343 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:27 UTC Exercise / conversionCommon Stock 2,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-23-000046 · wk-form4_1687386442.xml · nonDerivative · entry 1

Crane Rosemary A · CIK 0001443343 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:08 UTC Exercise / conversionRestricted Stock Units · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000041 · wk-form4_1687385320.xml · derivative · entry 2

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:08 UTC Exercise / conversionCommon Stock 2,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-23-000041 · wk-form4_1687385320.xml · nonDerivative · entry 1

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,632

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:21 UTC Exercise / conversionRestricted Stock Units · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000044 · wk-form4_1687386067.xml · derivative · entry 2

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:21 UTC Exercise / conversionCommon Stock 2,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-23-000044 · wk-form4_1687386067.xml · nonDerivative · entry 1

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:25 UTC Exercise / conversionRestricted Stock Units · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000045 · wk-form4_1687386330.xml · derivative · entry 2

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:25 UTC Exercise / conversionCommon Stock 2,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-23-000045 · wk-form4_1687386330.xml · nonDerivative · entry 1

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:18 UTC Exercise / conversionRestricted Stock Units · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000043 · wk-form4_1687385913.xml · derivative · entry 2

Goldberg Andrew D. · CIK 0001827722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:18 UTC Exercise / conversionCommon Stock 2,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-23-000043 · wk-form4_1687385913.xml · nonDerivative · entry 1

Goldberg Andrew D. · CIK 0001827722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:14 UTC Exercise / conversionRestricted Stock Units · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000042 · wk-form4_1687385681.xml · derivative · entry 4

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 22:14 UTC Exercise / conversionCommon Stock 2,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-23-000042 · wk-form4_1687385681.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 14, 2023 Filed Jun 16, 2023 20:48 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 9,000 $18.58 $167,220.00
Disclosure

SEC source: 0001827672-23-000033 · wk-form4_1686948523.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 1,031,006

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $18.17 to $18.95. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
June 08, 2023 Filed Jun 12, 2023 21:40 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 3,100 $20.01 $62,031.00
Disclosure

SEC source: 0001209191-23-036433 · doc4.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 1,040,006

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $20.00 to $20.06. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
June 08, 2023 Filed Jun 12, 2023 21:25 UTC
Mottiwala AzizChief Commercial Officer
SaleCommon Stock 100 $20.00 $2,000.00
Disclosure

SEC source: 0001209191-23-036395 · doc4.xml · nonDerivative · entry 1

Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,086

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 23:16 UTC
Mottiwala AzizChief Commercial Officer
SaleCommon Stock 2,500 $19.34 $48,350.00
Disclosure

SEC source: 0001209191-23-035579 · doc4.xml · nonDerivative · entry 2

Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,186

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022.

F3 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $19.02 to $19.62. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 23:16 UTC
Mottiwala AzizChief Commercial Officer
SaleCommon Stock 2,143 $18.61 $39,881.23
Disclosure

SEC source: 0001209191-23-035579 · doc4.xml · nonDerivative · entry 1

Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,686

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $18.07 to $18.86. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 17, 2023 Filed May 19, 2023 23:08 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 8,000 $15.90 $127,200.00
Disclosure

SEC source: 0001827672-23-000031 · wf-form4_168453770654909.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 1,043,106

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.72 to $16.26. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
May 11, 2023 Filed May 15, 2023 21:57 UTC OtherCommon Stock 41,219 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-029596 · doc4.xml · nonDerivative · entry 2

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Flying L Partners XI, LLC

Disclosed balance after: 109,892

F3 · kind: Represents the receipt of shares from a pro-rata in-kind distribution, and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners.

F4 · ownership.nature: The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.

Read SEC document
May 11, 2023 Filed May 15, 2023 21:57 UTC OtherCommon Stock 215,576 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-029596 · doc4.xml · nonDerivative · entry 1

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Flying L Investments XI, LLC

Disclosed balance after: 0

F1 · kind: Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners pursuant to a 10b5-1 plan entered into by Flying L Investments XI, LLC on May 19, 2022.

F2 · ownership.nature: The shares are held directly held by Flying L Investments XI, LLC. The Reporting Person is the manager of Flying L Investments XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.

Read SEC document
May 10, 2023 Filed May 12, 2023 21:08 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 9,000 $16.80 $151,200.00
Disclosure

SEC source: 0001827672-23-000030 · wf-form4_168392571200364.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 1,051,106

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $16.37 to $17.03. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
May 01, 2023 Filed May 2, 2023 23:06 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 5,841 $15.10 $88,199.10
Disclosure

SEC source: 0001827672-23-000028 · wf-form4_168306879822123.xml · nonDerivative · entry 2

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 1,060,106

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.

F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
April 28, 2023 Filed May 2, 2023 23:06 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 4,278 $15.13 $64,726.14
Disclosure

SEC source: 0001827672-23-000028 · wf-form4_168306879822123.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 1,065,947

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.26. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:05 UTC
Farrow Jeffrey SSee Remarks
GrantRestricted Stock Units · Derivative 111,525 $0.00 $0.00
Disclosure

SEC source: 0001819790-23-000020 · wf-form4_168254308276163.xml · derivative · entry 2

Farrow Jeffrey S · CIK 0001405253 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,525

Underlying: Common Stock · 111,525 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service.

F3 · derivative.expiration_date: 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service.

Read SEC document
April 24, 2023 Filed Apr 26, 2023 21:05 UTC
Farrow Jeffrey SSee Remarks
GrantStock Option (right to buy) · Derivative 163,397 $0.00 Strike: $14.62 $0.00
Disclosure

SEC source: 0001819790-23-000020 · wf-form4_168254308276163.xml · derivative · entry 1

Farrow Jeffrey S · CIK 0001405253 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,397

Underlying: Common Stock · 163,397 shares

Expires 2033-04-23

F1 · derivative.exercise_date: 25% of the option shares shall vest on April 24, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.

Read SEC document
April 21, 2023 Filed Apr 25, 2023 21:22 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 2,311 $15.03 $34,734.33
Disclosure

SEC source: 0001827672-23-000026 · wf-form4_168245771899403.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 1,070,225

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
April 20, 2023 Filed Apr 21, 2023 21:53 UTC
Greenstein Leonard M.Chief Financial Officer
SaleCommon Stock 5,000 $14.02 $70,100.00
Disclosure

SEC source: 0001519692-23-000012 · wf-form4_168211398207180.xml · nonDerivative · entry 1

Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,785

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $13.64 to $14.54. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 19, 2023 Filed Apr 21, 2023 21:49 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 8,000 $13.60 $108,800.00
Disclosure

SEC source: 0001827672-23-000024 · wf-form4_168211375019028.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 1,072,536

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $13.13 to $14.03. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
March 23, 2023 Filed Mar 24, 2023 00:04 UTC
Greenstein Leonard M.Chief Financial Officer
SaleCommon Stock 346 $12.15 $4,203.90
Disclosure

SEC source: 0001519692-23-000010 · wf-form4_167961628683110.xml · nonDerivative · entry 3

Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,785

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 23, 2023 Filed Mar 24, 2023 00:02 UTC
Trevejo Jose M.CHIEF MEDICAL OFFICER
SaleCommon Stock 465 $12.15 $5,649.75
Disclosure

SEC source: 0001661539-23-000004 · wf-form4_167961616570410.xml · nonDerivative · entry 3

Trevejo Jose M. · CIK 0001661539 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,107

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 23, 2023 Filed Mar 23, 2023 23:56 UTC
Neervannan SeshadriChief Operating Officer
SaleCommon Stock 390 $12.15 $4,738.50
Disclosure

SEC source: 0001827584-23-000004 · wf-form4_167961578319952.xml · nonDerivative · entry 3

Neervannan Seshadri · CIK 0001827584 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,696

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 23, 2023 Filed Mar 23, 2023 23:52 UTC
Wahl BryanGeneral Counsel
SaleCommon Stock 371 $12.15 $4,507.65
Disclosure

SEC source: 0001841401-23-000004 · wf-form4_167961555155059.xml · nonDerivative · entry 3

Wahl Bryan · CIK 0001841401 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,402

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 23, 2023 Filed Mar 23, 2023 23:50 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 737 $12.15 $8,954.55
Disclosure

SEC source: 0001827672-23-000022 · wf-form4_167961543559554.xml · nonDerivative · entry 3

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,597

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 23, 2023 Filed Mar 23, 2023 23:48 UTC
Whitfield Dianne C.Chief Human Resources Officer
SaleCommon Stock 345 $12.15 $4,191.75
Disclosure

SEC source: 0001839516-23-000004 · wf-form4_167961530701522.xml · nonDerivative · entry 3

Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,219

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the previously reported vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 23, 2023 Filed Mar 23, 2023 23:46 UTC
Mottiwala AzizChief Commercial Officer
SaleCommon Stock 372 $12.15 $4,519.80
Disclosure

SEC source: 0001788542-23-000004 · wf-form4_167961515955541.xml · nonDerivative · entry 3

Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,829

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 22, 2023 Filed Mar 24, 2023 00:04 UTC
Greenstein Leonard M.Chief Financial Officer
SaleCommon Stock 332 $12.64 $4,196.48
Disclosure

SEC source: 0001519692-23-000010 · wf-form4_167961628683110.xml · nonDerivative · entry 2

Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,131

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 22, 2023 Filed Mar 24, 2023 00:02 UTC
Trevejo Jose M.CHIEF MEDICAL OFFICER
SaleCommon Stock 529 $12.64 $6,686.56
Disclosure

SEC source: 0001661539-23-000004 · wf-form4_167961616570410.xml · nonDerivative · entry 2

Trevejo Jose M. · CIK 0001661539 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,572

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 22, 2023 Filed Mar 23, 2023 23:56 UTC
Neervannan SeshadriChief Operating Officer
SaleCommon Stock 379 $12.64 $4,790.56
Disclosure

SEC source: 0001827584-23-000004 · wf-form4_167961578319952.xml · nonDerivative · entry 2

Neervannan Seshadri · CIK 0001827584 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,086

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 22, 2023 Filed Mar 23, 2023 23:52 UTC
Wahl BryanGeneral Counsel
SaleCommon Stock 357 $12.64 $4,512.48
Disclosure

SEC source: 0001841401-23-000004 · wf-form4_167961555155059.xml · nonDerivative · entry 2

Wahl Bryan · CIK 0001841401 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,773

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.